相关实验视频
Updated: Jun 19, 2025
06:34
The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability
Published on: April 28, 2022
4.7K
综合饮食抗氧化剂指数与脏贫血有关:一个横截面研究
Liling Zhang1, Defeng Yin2, Tingting Zhu1
1Department of Nephrology, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
International urology and nephrology
|July 23, 2024
概括
通过综合饮食抗氧化剂指数 (CDAI) 测量较高的饮食抗氧化剂摄入量,与慢性病 (CKD) 患者贫血风险较低有关. 这项研究揭示了显著的逆相关性,表明饮食中的抗氧化剂可能起着保护作用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 营养科学 营养科学
- 氧化压力研究研究 氧化压力研究
背景情况:
- 慢性病 (CKD) 越来越多地与氧化压力有关.
- 饮食中的抗氧化剂被认为是CKD的潜在预防剂.
- 综合饮食抗氧化剂指数 (CDAI) 对脏贫血的具体影响尚不清楚.
研究的目的:
- 调查CDAI与脏贫血患病率之间的关系.
- 为了确定较高的CDAI是否与贫血的可能性降低有关.
- 探索这种关系的性质,包括潜在的非线性关联.
主要方法:
- 为5880名参与者计算CDAI的标准化计算.
- 二元回归分析以评估CDAI和脏贫血之间的关联.
- 限制立方斜线曲线以检查非线性关系并确定拐点.
- 小组分析以确认发现的可靠性.
主要成果:
- 在CDAI和贫血之间观察到显著的反相关性 (P < 0.0001).
- 多变量分析显示,增加CDAI的脏贫血的几率比为0.96 (95% CI:0.94,0.98).
- 在CDAI 6.005的拐点确定了非线性关系;在此之前,脏贫血的患病率在CDAI增加单位下降了5.7%.
- 亚组分析显示没有显著的相互作用效应.
结论:
- 在CDAI和贫血之间存在非线性,负相关性.
- 饮食中增加的抗氧化剂摄入量可能会在CKD的背景下保护脏贫血.
- 需要进一步的大规模前性研究来证实因果关系.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
71
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
71
01:11Renal Failure: Dose Adjustments
78
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
78